Scientists test supercharged immune cells to fight tough cancers
NCT ID NCT07349160
Summary
This early-phase study is testing the safety and effectiveness of a new type of cell therapy for people with advanced solid tumors that have not responded to standard treatments. Doctors will collect a patient's own immune cells from a tumor, modify them in a lab to potentially work better, and then infuse them back into the patient. The main goal is to see if this treatment is safe and if it can shrink tumors or slow their growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, 100000, China
Contact
Contact
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.